UPC
Universe Pharmaceuticals INCPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Jun 26 ▼ Universe Pharmaceuticals (UPC) announced a share purchase agreement…
- Jun 26 M&A: Universe Pharmaceuticals INC Announces Strategic Acquisiti…
- Aug 14 ▼ Short interest jumps 454.7% to 35.4K
- Sep 2 Trading halt: Halt Resumed: UPC, trading resumed after LUDP (Volatility…
- Sep 2 Trading halt: Trading Halt: UPC, LUDP (Volatility Trading Pause)
- Sep 15 ▼ Short interest jumps 154.8% to 75.8K
- Sep 30 ▲ Short interest falls 42.2% to 43.9K
- Oct 15 ▲ Short interest falls 30.9% to 30.3K
- Oct 30 ▼ Short interest jumps 38.4% to 41.9K
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- InstitutionsMIXED
Q3 2026: 0 added (0 new), 1 trimmed or exited.
- Short sellersBUILDING
Short interest +38.4% to 41.9K shares. 1.0 days to cover, ≈0.8% of shares.
- TrendDOWNTREND
58% below its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| UBS Group AG | NEAR_EXIT | $6.7K |
Quarterly 13F filings are due 45 days after each quarter ends.
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Lai Gang Chief Executive Officer May 7, 2026 | AWARD | 12,610 sh |
Lai Gang Chief Executive Officer May 7, 2026 | AWARD | 71,890 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | None | None | No data | $0.00 |
| Next Q | None | None | No data | $0.00 |
| Current FY | None | None | No data | $0.00 |
| Next FY | None | None | No data | $0.00 |
Short side
FINRA· Oct 30, 2026| Sep 2, 2026 | Volatility Pause | Resumed |
SecBot reports
3 filings · 0 bullish · 3 bearish- BEARISH EFFECTOct 13, 2026
The SEC declared effective Universe Pharmaceuticals' F-3 shelf registration (File No. 333-299191)…
Monitor for subsequent prospectus supplements or takedown notices under the shelf, which would reveal the actual offering size and terms. The effectiveness alone creates a standing dilution overhang…
- BEARISH 6-KOct 6, 2026
Universe Pharmaceuticals reported the results of its 2026 Annual General Meeting held on September…
The reverse split authorization signals management's expectation that the stock may fall below $1.00, risking Nasdaq delisting. Monitor UPC's price action, if it approaches $1.00, the split trigger…
- BEARISH 6-KJun 26, 2026
Universe Pharmaceuticals (UPC) announced a share purchase agreement to acquire 100% of Best Praise…
The massive stock-based consideration relative to the current float will likely pressure the stock as the market prices in severe dilution. Monitor for shareholder approval and Nasdaq listing…
All UPC filing & press-release reports (3)
- EFFECT reportOct 13, 2026
- 6-K reportOct 6, 2026
- 6-K reportJun 26, 2026